Tolerance to parenchymal self. Regulatory role of major histocompatibility complex-restricted, OX8+ suppressor T cells specific for autologous renal tubular antigen in experimental interstitial nephritis by unknown
TOLERANCE  TO  PARENCHYMAL  SELF 
Regulatory Role of Major Histocompatibility Complex-restricted, 
OX8 + Suppressor T  Cells Specific for Autologous Renal Tubular 
Antigen in Experimental Interstitial Nephritis 
BY  CAROLYN J. KELLY,  WILLYS K. SILVERS,  AND ERIC G. NEILSON 
From the Renal-Electrolyte Section of the Department of  Medicine, and the Department of 
Human Genetics, University of Pennsylvania School of Medicine, 
Philadelphia, Pennsylvania 19104 
New information continues to emerge regarding basic immunologic mecha- 
nisms of self-tolerance. While tolerance is often defined at the T  or B cell level 
(1),  the overall process can also be categorized by mechanisms mediated either 
by the deletion of self-reactive clones, the effects of suppressor T cell surveillance, 
or  the  sequential  action  of both  processes  (2).  Such  mechanisms have  been 
intensively analyzed in the context of strategies designed to induce immunologic 
unresponsiveness to histocompatibility antigens on lymphocytes, skin, and most 
transplantable organs (3-6). Current evidence, however, has not directly estab- 
lished whether such  findings  can  be  extended to  the  prevention of antigen- 
specific autoimmunity to non-major histocompatibility complex (MHC) 1 paren- 
chymal self. 
Therefore, taking advantage of the genetic polymorphisms that are involved 
with the susceptibility of rats to autoimmune interstitial nephritis (7),  we have 
investigated the mechanism of tolerance to autologous renal tubular antigen. In 
this model, prototypically susceptible Brown Norway (BN) rats immunized with 
rabbit, but not with BN, renal tubular antigens develop anti-tubular basement 
membrane antibodies  (a-TBM-Ab) and an  intense mononuclear cell infiltrate 
producing severe interstitial nephritis. Previously, we showed that susceptibility 
to this lesion in rats principally requires both the genetically determined expres- 
sion of the relevant cortical tubular antigen (TBM +) (7,  8) and the capacity to 
mount an MHC-linked, cell-mediated immune response to the antigen (7).  We 
now demonstrate that the induction of tolerance to TBM first requires antigen 
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expression, and is then largely attributable to the presence of an antigen-specific, 
cyclophosphamide-sensitive,  OX8 + suppressor  T  cell  that  is restricted  by gene 
products in the MHC. 
Materials and  Methods 
Animals.  Brown Norway (BN) and Lewis (LEW) rats were obtained from the Charles 
River Breeding Laboratories, Wilmington, MA. Lewis. 1N (LEW. 1N), Fischer.BN (F.BN), 
(LEW.1N  ×  LEW)F~,  and  (BN  ×  LEW)F~  hybrids  were  bred  at  the  University  of 
Pennsylvania.  MHC  (RT1  in  the  rat) genotypes as well as the presence or absence of 
TBM  + in the animals are as follows: BN (RTI"/TBM+), LEW (RTP/TBM-),  LEW.1N 
(RTI"/TBM-), F.BN (RTI"/TBM+), (LEW.1N  ×  LEW)F,  (RTI"~/TBM-), and (BN  × 
LEW)F, (RT I"/'/TBM÷). 
Induction of Neonatal  Tolerance.  Tolerance of BN antigens was induced by injecting 
neonatal  LEW.1N and  F.BN animals, <12 h  old,  with  50 ×  106 BN spleen and lymph 
node cells according to procedures described elsewhere (9). Neonatal (LEW. 1N × LEW)F1 
rats were rendered  tolerant of BN antigens with  50  ×  106 (LEW  ×  BN)F1 spleen and 
lymph node ceils.  In all cases tolerance was confirmed by the permanent acceptance of a 
BN skin graft. 
Preparation  of Renal  Tubular Antigens.  BN  rat  renal  tubular  basement  membrane 
antigens and BN liver membrane antigens were isolated by a differential sieving technique 
(10).  Highly enriched basement membrane fragments were sonicated,  lyophilized, and 
stored at  -70°C.  Soluble renal  tubular antigens (BN-TBM) and soluble liver antigens 
(BN-SLA) were made from these lyophilized membranes using collagenase digestion (7, 
11). 
Immunizations.  Groups of rats were immunized with  1 mg of BN-TBM in complete 
Freund's adjuvant (CFA) (0.5  ml; Mycobacterium tuberculosis, 2  rag/animal)  by footpad 
and/or subcutaneous injection. Control animals received CFA alone. Selected groups of 
animals received intraperitoneal cyclophosphamide; chronic administration  consisted of 
15 mg/kg on the day of immunization, followed by 2 mg/kg daily until sacrifice (day 28). 
Other animals received a single injection of 50 mg/kg 72 h before sacrifice (12). 
Elicitation  of Delayed-Type Hypersensitivity (DTH) Responses.  DTH  responses  to  BN- 
TBM and purified protein derivatives (PPD) were induced by subcutaneously immunizing 
rats with BN-TBM in CFA (13).  12-14 d after such immunizations, groups of rats were 
challenged in one footpad with 50 ug of soluble antigen (BN-TBM, BN-SLA, or PPD) in 
50 /~1 of phosphate-buffered saline (PBS).  Footpad  swelling, as an  index  of DTH, was 
measured 24 h  later using a spring-loaded engineer's micrometer (13) (Schlesingers for 
Tools Ltd.,  Brooklyn, NY).  The magnitude of swelling was expressed as the increment 
between the challenged footpad and the control, PBS-challenged footpad in inches ×  10  -~ 
_+ SEM. All measurements were cage blind. 
Adoptive Transfer Experiments.  Spleens and/or draining  lymph node cells were har- 
vested from donors  12-14 d after immunization and made into a single-cell suspension. 
The  cells  were  washed,  counted,  and  injected  intravenously  (20-25  ×  10 s  cells  per 
recipient) using 0.9% NaCI as the vehicle. 2-3 h after cell transfer, recipients were footpad 
challenged with antigens or PBS and footpad swelling was measured as described above. 
Preparation oflmmune Cell Subpopulations.  Cell suspensions were T  cell depleted with 
a  monoclonal IgM anti-RT7.1  antibody (from BC84.5 hybridoma [14,  15] provided by 
Dr. John Ely and Dr. Frank Fitch, University of Chicago, Chicago, IL) and a mixture of 
rabbit and  guinea  pig complement.  Nylon  wool  T  (NWT)  and  nylon  wool-adherent 
(NWA) cells were obtained from packed nylon wool columns (3-4 ×  108 cells added to a 
35-ml column) according to standard methods (16). Monoclonal antibody OX8 (cytotoxic/ 
suppressor subset) was purchased from Accurate Chemical & Scientific Corp., Westbury, 
NY (I 7). The OX8 monoclonal antibody was used to enrich T cells by an indirect panning 
technique as described previously (18,  19). Briefly, 2.5 ml of affinity-purified rabbit anti- 
mouse IgG (Zymed Laboratories, San Francisco, CA) in a concentration of 1 mg/ml in 
PBS was incubated on 60 ×  15 mm polystyrene dishes overnight at 4°C. After removal 1894  TOLERANCE  TO  PARENCHYMAL  SELF 
of the IgG solution, the plates were washed and blocked with 5% fetal calf serum in PBS 
(PBS-5)  for 30 rain. The fetal calf serum was then washed out before the addition of the 
T  cells.  25 x  10  6 NWT were preincubated in 0.2 ml of a  1:40 dilution of OX8 antibody 
(ascites fluid) for 30 min at 4°C. After extensive washing in PBS, the cells were transferred 
onto the anti-IgG-coated dishes for 60 min at 22°C. Midway through the incubation the 
dishes were gently rocked. Nonadherent cells were removed from the plates with three 
cycles of swirling and washing with PBS-5. After the nonadherent cells were removed, 3 
ml of chilled PBS-5 was added to the dishes, which were then placed at 4°C for 30 min. 
The adherent cells were then resuspended by vigorous pipetting and further washed with 
chilled PBS-5.  The presence of Ig  ÷ cells  in the separation mixture was determined by 
direct immunofluorescence using rhodamine isothiocyanate (RITC)-anti-rat Ig (gift of 
Dr. Susan Webb, Scripps Clinic and Research Foundation, LaJolla, CA) and the percent- 
age of OX8 ÷ cells was determined by indirect fluorescence using FITC-anti-mouse IgG 
(Cappel Laboratories, Cochranville, PA). 
Assessment of Renal Disease.  Kidney tissue was prepared for immunofluorescent and 
light microscopy by standard methods for this laboratory (20).  The degree of interstitial 
involvement  was  quantitatively  determined  from  coded,  paraffin-embedded  kidneys 
stained with hematoxylin and eosin. Cellular infiltration and tubular damage leading to 
cortical interstitial destruction was graded on a scale of 0 to 4 as follows: 0, normal; 0.5, 
small focal areas of cellular infiltration and tubular damage involving <10% of the cortex; 
2, involvement up to 25% of the cortex; 3, involvement up to 50-75% of the cortex; and 
4, extensive damage involving >75% of the cortex. Scores for each experimental group 
were read blind, averaged, and expressed as a mean +  SEM. Direct immunofluorescence 
of tubular staining by c~-TBM-Ab was graded 0-4  + and expressed as a mean +  SEM for 
each group. 
Statistical Analysis.  Differences  between  experimental  groups  were  determined  by 
Student's t test. 
Results 
Characterization of the Immune Response to BN-TBM.  In an introductory series 
of experiments we observed that BN rats, when immunized with BN antigen in 
CFA (BN-TBM/CFA),  made small amounts of ~-TBM-Ab but did not  develop 
histologic  tubulointerstitial  nephritis  nor  a  significant  DTH  response  to  BN- 
TBM.  To  determine  whether  such  unresponsiveness  correlated  with  antigen 
presence  in  the  kidney,  we  also  immunized  RTI',  TBM +  (F.BN),  and  TBM- 
(LEW. 1 N) strains.  As noted in Table I, LEW. 1 N  and F.BN rats both developed 
a DTH  response to BN-TBM after immunization whereas BN rats did not; F.BN 
rats  also  developed  significant  tubulointerstitial  nephritis,  indicating  that  BN- 
TBM  is  capable  of  producing  disease.  When  alloreactivity  to  the  BN-TBM 
preparation was attenuated,  however, by neonatally tolerizing (T) LEW. 1 N  and 
F.BN  rats  to  BN  alloantigen,  we  obtained  very  different  results.  Although 
LEW.1N(T)  animals  still  displayed  a  DTH  response  to  BN-TBM,  F.BN(T) 
developed  neither  histologic  disease  nor  a  DTH  response  after  immunization 
with BN-TBM.  The  DTH  response to  PPD was comparable among all groups. 
These results suggest that, with abrogation of alloreactivity, background dispar- 
ate TBM + strains fail to respond  to  BN-TBM,  whereas TBM-  strains continue 
to recognize BN-TBM. 
Further studies demonstrated the feasibility of using the DTH  response of an 
immunized RTln/TBM -  strain as a  measure of cell-mediated immunity to BN- 
TBM. As noted in Table II, immune lymphocytes from LEW.1N(T) donors can 
adoptively  transfer  this  response  into  naive  LEW.1N  recipients.  The  lack  of KELLY,  SILVERS,  AND  NEILSON 
TABLE  I 
Immune Response to BN-TBM 
1895 
Direct fluo- 
Immuni-  rescence of  Histologic$ 
Strain*  zation  bound  disease 
a-TBM-Ab 
DTH Response  9 
BN-TBM  PPD 
BN  +  0.6 ±  0.2  0.0  3.8 4-  1.4  29.6 ±  5.5 
BN  -  0.0  0.0  5.0 ±  1.0  27.1 4- 2.1 
F.BN  +  2.8 ±  0.4  2.4 ±  0.3  27.6 4- 2.9 m  26.0 ±  2.5 
F.BN  -  0.0  0.0  6.6 4- 0.3  28.0 4- 1.8 
LEW.IN  +  0.0  0.0  31.6 4- 1.81  31.0 +  4.5 
LEW.1N  -  0.0  0.0  4.3 4- 0.9  28.3 4- 2.3 
F.BN(T)  +  0.6 ±  0.1  0.1  ±  0.1  7.5 ±  1.8"*  31.0 ±  3.1 
F.BN(T)  -  0.0  0.0  3.5 4- 0.5  26.0 ±  2.0 
LEW.1N(T)  +  0.0  0.0  33.5 4- 0.51  33.0 4- 7.0 
LEW.1N(T)  -  0.0  0.0  6.5 ±  0.5  23.0 +  4.2 
* Animals were immunized with BN-TBM/CFA (+) or CFA alone (-). 
* Kidneys were harvested 28 d after immunization. 
9 Animals were challenged with antigens in the footpad of each hindleg; footpad measurements 
were  made before and  24  h  after antigen challenge. Data are calculated as the mean footpad 
increment in inches ×  10  -3 ±  SEM. 
n p  <  0.001  compared with CFA-immunized controls. 
** P <  0.005 compared with immunized F.BN. 
TABLE  II 
Adoptive Transfer of DTH 
Donor Cells*  Treatment 
DTH Response* 
BN-SLA  BN-TBM  PPD 
Immune LEW. IN(T)  I  5.0 ±  0.5  19.5 4- 1.59  18.5 ±  0.59 
Immune LEW. IN(T)  C'  --  2t.8 +  1.1 ~  21.0 ±  1.0  ~ 
Immune LEW. IN(T)  ~x-RT7.1  +  C'  --  3.8 ±  1.3  4.3 4- 0.3 
Control LEW. 1N(T)  --  4.7 4- 0.6  5.6 ±  0.9  26.0 ±  7.01 
--  --  --  4,6  ±  0.3  5.0 ±  0.6 
* Donor lymph node and spleen cells harvested from animals immunized 14 d previously with BN- 
TBM/CFA (immune) or CFA alone (control) were transferred intravenously into naive LEW. 1N 
recipients (20 ×  106 pooled lymph node cells and spleen cells per recipient.) 
* Recipients were challenged at time of cell transfer and mean footpad increment in inches ×  10  -3 
+  SEM (n =  4) was determined 24 h later. 
9 p  <  0.001 compared with recipients of no cells. 
P <  0.05 compared with recipients of no cells. 
reactivity  to  BN-SLA  suggests  that  the  BN-TBM  response  is  antigen  specific. 
Treatment  of  the  immune  cells  with  an  anti-T  cell  antibody  (a-RT7.1)  and 
complement  completely  abrogated  the  DTH  response,  suggesting  that  it was  T 
cell mediated.  There  was no significant  difference  in DTH  response  to BN-TBM 
between  recipients  of  cells  from  CFA-immunized  donors  and  recipients  of  no 
cells.  Therefore,  in  subsequent  studies,  either  group  was  used  as  a  negative 
control 
Genetic Restriction  of the DTH Response to BN-TBM.  We  used  this acute  adop- 
tive  transfer  assay  to  study  the  genetic  requirements  for  expression  of  DTH 
reactivity.  As  seen  in  Table  III,  lymphocytes  from  immunized  LEW.1N(T) 1896  TOLERANCE  TO  PARENCHYMAL  SELF 
TABLE  III 
RT1 Restriction of DTH to BN-TBM 
Donor Cells* 
DTH response to BN-TBM* 
LEW.1N  LEW  (LEW. IN × 
LEW)FI 
Immune LEW.1N(T)  22.7 4- 0.9§  5.0 4- 0.4  -- 
Immune LEW(T)  4.8 4- 0.6  23.0 +  1.2  §  -- 
Immune (LEW.1N X LEW)F~(T)  25.0 4- 2.2 g  25.8 4-  1.6  j  27.8 4-  1.1 § 
--  5.3  4-  0.3  4.0 4- 0.6  5.8 _+ 0.8 
* Pooled lymph node cells and spleen cells from animals immunized 14 d earlier with BN-TBM/CFA 
were transferred intravenously into naive recipients (20  X  106 cells per recipient). Animals were 
footpad challenged immediately after cell transfer. 
* See Table II. 
§ P <  0.001  compared with controls. 
TABLE  IV 
Demonstration of Suppressor T Cells to BN-TBM in BN Rats 
Donor cells*  DTH Response* 
Treatment of BN cells 
LEW. 1N(T)  BN  BN-TBM  PPD 
Immune  --  --  22.8 +  3.4  21.3 ___ 2.7 
Immune  Immune  --  5.0 -  0.5  ~  18.3 +  1.7 
hnmune  Immune  C'  5.0 +  0.40  21.0 -  1.7 
Immune  Immune  a-RT7.1  +  C'  21.8 +  1.8  20.6 4-  1.0 
Immune  Immune (CTX)  --  18.6 4- 2.4  -- 
lmmune  Control  --  20.8 4- 2.4  20.2 4- 0.8 
Immune  Normal thymus  --  7.04- 2.1H  21.5 4-  1.6 
--  Immune  --  4.6 4- 0.3 a  19.6 +  1.8 
Control  --  --  5.6 4- 0.90  22.3 4-  1.8 
* Donor lymph node and spleen cells [LEW.1N(T)] or lymph node cells (BN) were harvested from 
rats immunized 10-14 d earlier with BN-TBM/CFA (immune) or CFA (control). CTX (50 mg/kg) 
was administered, where indicated, intraperitoneally to BN rats 72 h before sacrifice. Equal numbers 
(20  x  106) of LEW. 1N(T) and  BN  cells  were admixed and transferred intravenously into naive 
LEW. 1N recipients. 
* See Table II. 
§ P <  0.005 compared with response with LEW. 1N(T) donor cells. 
I p  <  0.01  compared with response with LEW. 1N(T) donor cells. 
donors could not transfer a DTH response into LEW recipients; LEW(T) donor 
cells could transfer this response into LEW, but not to LEW. 1N recipients. The 
adoptive  transfer  of  immunized  (LEW.1N  x  LEW)Fl(T)  donor  cells  into 
LEW. 1  N, LEW, and (LEW. 1N ×  LEW)F1 recipients confirmed previous obser- 
vations  that  acute  rejection  is  not  an  adequate  explanation  for  the  failure  to 
observe a DTH response in RT1 disparate recipients (21). 
Demonstration  of Suppressor  T  Cells  in BN Rats.  We wished to determine  if 
active suppression might explain the lack of immunologic reactivity observed in 
BN rats immunized with BN-TBM. In Table IV it can be observed that admixture 
of immune  lymph  node  cells  from  BN  rats  with  immune  LEW.1N(T)  cells 
resulted  in  complete  suppression  of the  DTH  response  to  BN-TBM  in  naive 
LEW.1N  recipients.  This  suppression  was  abrogated  by pretreatment  of the 
immune  BN lymphocytes with the anti-T  cell antibody and complement,  indi- KELLY,  SILVERS,  AND  NEILSON 
TABLE  V 
Antigen-specific Suppression of DTn to BN-TBM by OX8  ÷ Lymphocytes 
1897 
Donor ceils*  DTH response  ¢ 
Cell dose 
LEW. 1 N(T)  BN  BN-TBM  PPD 
Immune  --  --  23.0 ±  1.0  27.3 ±  2.2 
Immune  Immune Unfractionated  25 X  106  5.0 ±  1.04  23.3 -  2.4 
Immune  Immune NWT  15 ×  106  6.3 ±  1.84  23.0 ±. 2.5 
Immune  Immune NWA  15 X  106  24.3 ±  0.8  27.3 ±  2.7 
Immune  Immune OX8 ÷  2.5 X  106  4.2 ±  0.90  21.8 ±  0.8 
Immune  Immune OX8-  13.5 X  106  21.7 ±  1.1  23.2 ±  0.5 
Control (CFA)  --  --  5.3 ±  0.84  27.3 ±  0.8 
*  Pooled  lymph node and spleen cells [LEW.1N(T)]  and selected populations of lymph node cells 
(BN) were harvested from rats immunized 14 d  earlier with BN-TBM]CFA or CFA, and injected 
intravenously into naive LEW. 1N recipients. NWT  and NWA represent nylon wool-nonadherent 
and -adherent populations; OX8 ÷, NWT that bind OX8 antibodies; OX8-, NWT that do not bind 
OX8 antibodies. 
* See Table II. 
0 p  <  0.001  compared with response with immune LEW.1N(T) donor cells. 
cating that  suppression  was mediated by T  lymphocytes. Suppression  was also 
eliminated  by  cyclophosphamide  pretreatment  of an  immunized  BN  rat  cell 
donor. 
As noted in Table V, nylon wool separation  of the immune BN lymphocytes 
(a separation resulting in <3-5% Ig  + cells in the nonadherent fraction) confirmed 
that  the  suppression  resided  in  the  enriched  T  cell preparation.  These  NWT 
cells were  further  separated  into  OX8-  or  OX8  + subpopulations  by indirect 
panning.  The  adherent  population  obtained  by  indirect  panning  was  -90% 
OX8 +.  This  represented  15-17%  of the  starting  lymph  node  T  cells.  The 
nonadherent  T  cells were 90% OX8-. Only the OX8 + subpopulation displayed 
suppression.  The  data  in  Tables  IV  and  V  consistently  demonstrate  that  the 
suppression was antigen specific, since the DTH response to PPD was unaffected. 
Although this suppressor cell could not be identified in the peripheral lymphoid 
organs  of CFA-immunized  BN  rats  (Table  IV),  it  was  present  in  harvested 
thymocyte preparations. 
Genetic  Restriction of the Antigen-specific Suppressor  T  Cell.  We examined the 
ability of immune lymphocytes from BN rats to suppress the DTH reactivity of 
immune  cells  from  disparate  strains.  We  found  that  immune  cells  from  BN 
donors  suppressed  the  BN-TBM  DTH  reactivity  of  immune  cells  from 
LEW.1N(T) but not LEW(T) rats (Table VI). We did not have an RTll/TBM + 
strain to directly test its effect on DTH-reactive RT 11/TBM- lymphocytes. Donor 
suppressor T  cells from immune (BN x  LEW)F1 hybrids (TBM+), however, were 
able to inhibit  DTH-reactive cells from immune  LEW.IN and  LEW rats,  indi- 
cating that the LEW response was also suppressible. 
Role of the Suppression  in Preventing the Development  of Interstitial Nephritis to 
Autologous TBM.  Since the presence of cyclophosphamide-sensitive suppressor 
T  cells correlated with unresponsiveness to BN-TBM (Table IV) in BN rats, we 
examined the effect of cyclophosphamide (CTX) therapy on disease expression 
in immunized animals (22). In pilot studies we observed that BN rats receiving a 
single injection of CTX (50 mg/kg) immediately before immunization with BN- 1898  TOLERANCE  TO  PARENCHYMAL  SELF 
TABL~ VI 
RT1 Restriction  of BN Suppressor  Cell to BN-TBM 
Donor cells* 
DTH  reactive  Suppressor cell 
DTH  response to 
BN-TBM  * 
Immune LEW. 1N(T)  --  28.3 ±  3.9 
Immune LEW(T)  --  27.3 ±  1.5 
Immune LEW. 1N(T)  Immune BN  6.3 ±  0.30 
Immune LEW(T)  Immune BN  28.3 _+ 2.2 
Immune LEW. l N(T)  Immune (BN ×  LEW)Ft  5.7 ±  1.5  ~ 
Immune LEW(T)  Immune (BN x  LEW)FI  6.0 ±  1.0  ! 
--  --  3.3  ±  0.3 
*  20 x  106 immune cells from day-I 4  LEW. 1N(T) or LEW(T) rats were injected alone or admixed 
with equal numbers ofday-I 4 BN or (BN x  LEW)Fj immune lymph node cells, into naive (LEW. 1N 
x  LEW)FI recipients. 
* See Table II. 
§ P  <  0.005 compared with response with LEW. 1N(T) donor cells. 
TABLE  VII 
Role of suppressor Cells in Preventing Interstitial Nephritis in BN Rats 
Direct fluores-  Histologic  DTH response  ! 
lmmuni-  Treatment  cence of bound 
zation*  a-TBM-Ab  disease*  BN-TBM  PPD 
-  --  0.0  0.0  5.0±1.6  22.0±0.6 
+  --  0.5±0.3  0.0  5.5±0.3  25.5±0.6 
+  CTX  3.0±0.4  2.0±0.8  19.5±1.7  jl  20.0±2.0 
-  CTX  0.0  0.0  4.7±0.9  24.3±5.8 
* BN  rats  were  immunized  with  IaN-TBM/CFA  (+)  or  CFA  alone  (-).  Selected  groups  were 
concomitantly treated  with  cyclophosphamide (CTX)  intraperitoneally,  15  mg/kg on  the day of 
immunization and 2  mg/kg daily thereafter until sacrifice. 
Histo]ogic disease was assessed 28 d  after immunization. 
§ DTH  responses were measured 14 d  after immunization as described in Table I. 
m  p  <  0.005 compared with control CTX. 
TBM/CFA did not develop histologic lesions (data not shown). Daily treatment 
of immunized  BN  rats  with  low dose CTX,  however, resulted  in  a  significant 
DTH response to BN-TBM as well as bistologic interstitial nephritis (Table VII). 
This  interstitial  lesion  was qualitatively indistinguishable  from those seen after 
immunization  with  heterologous  renal  tubular  antigen.  CTX-treated  rats  dis- 
played more marked deposition of a-TBM-Ab compared with non-CTX-treated 
BN  rats;  circulating  o~-TBM-Ab titers  by radioimmunoassay  also  were signifi- 
cantly higher (data not shown). 
Discussion 
These  studies  illustrate  several  interesting  findings  regarding  the control  of 
the  immune  response  to  autologous  parenchymal  tubular  antigen.  BN  rats 
immunized  with  BN-TBM  failed  to  develop  interstitial  nephritis  or  a  cell- 
mediated immune response.  This is in sharp contrast to the severe,  progressive 
lesion  that  develops  in  the same strain after  immunization  with  rabbit antigen 
(7, 23).  Previous work (13) in BN rats immunized with heterologous antigen has KELLY,  SILVERS,  AND  NEILSON  1899 
shown that  the DTH response to TBM correlates well with disease expression. 
By using RT1 n, TBM  +, or TBM- strains neonatally tolerized to BN alloantigens, 
we observed that  TBM- strains  mounted  a  cell-mediated immune  response to 
BN-TBM, whereas TBM  + strains did not. Acute adoptive transfer studies verified 
that the DTH response of immunized LEW.IN(T) rats was antigen specific and 
mediated by T  lymphocytes. Expression of this effector function was restricted 
by gene products in RT 1 (Table III). Admixture of immune BN cells with DTH- 
reactive  lymphocytes  from  RTln/TBM -  rats  also  resulted  in  antigen-specific 
suppression of the  DTH response.  This  suppression was mediated by an RT1- 
restricted,  OX8 +, cyclophosphamide-sensitive T  cell present in immune periph- 
eral lymph nodes. Suppression was also mediated by thymocytes from naive BN 
rats, and abrogation of this suppression by low-dose cyclophosphamide therapy 
resulted  in  significant  a-TBM-Ab  deposits,  DTH  responsiveness to  BN-TBM, 
and histologic interstitial  nephritis. 
Several of these findings require additional  elaboration.  It appears that allo- 
reactivity to the immunizing antigen facilitates the development of autoimmune 
interstitial lesions, as evidenced by the results comparing F.BN and F.BN(T) rats 
immunized with BN-TBM. The alioreactivity exhibited by F.BN was conceivably 
directed against  BN ailo-determinants  on  the  relevant nephritogenic  moieties, 
or  other  allotypic  markers  in  the  immunizing  preparation.  Thus,  although 
immune  LEW.1N and  LEW.1N(T) animals mount quantitatively similar  DTH 
responses to BN-TBM; presumably these are  qualitatively different  responses; 
that is, an immunized  LEW.1N rat probably exhibits (like F.BN) an antialloan- 
tigenic response in addition to an anti-TBM response. 
The immunologic control of immune responses to BN-TBM by BN rats may 
occur  at  different  levels  by  several  mechanisms.  Autoimmunity  is  probably 
contained to a certain degree by the fact that the T  cell response to BN-TBM is 
MHC restricted. Although it is only incompletely mapped in rats, helper/inducer 
T  cells  in  mice  are  restricted  by MHC  class  II  antigens  while  nephritogenic 
effector T  cells are  restricted  by class  I  determinants  (24,  25).  Since  class  II 
antigen is variably expressed at the tubular level, autorecognition  may be func- 
tionally minimized in the naive animal (work in progress). Since the BN rats that 
developed interstitial  lesions with  low-dose CTX (Table VII) were immunized 
with  BN-TBM/CFA,  an adjuvant  effect on the expression of RT1  antigens  at 
the tubular level cannot be fully excluded as a factor contributing to disease (26). 
Our data in this current report also suggest that immunization with parenchymal 
self-antigens  elicits  the expansion  of antigen-specific suppressor T  cells.  These 
cells are readily detected in the thymus of naive rats, but require immunization 
before they are observed in peripheral  lymphoid organs.  The relevance of this 
suppressor mechanism  to the maintenance  of self-tolerance is supported by the 
effects of daily  CTX  administration.  Daily  CTX,  in  a  dose  range  known  to 
preferentially affect suppressor T  cells (22, 27, 28), resulted in autoimmunity to 
TBM.  Although  a  more  direct  demonstration  of disease  protection  by these 
suppressor cells would use add-back strategies of appropriate  T  cell subpopula- 
tions, the requirement of daily CTX treatment to produce lesions in immunized 
BN rats eliminated  this as an option.  We also demonstrated  that  suppressor T 
cell function was RT 1 restricted in its mediation of effect. This finding highlights 1900  TOLERANCE TO  PARENCHYMAL SELF 
a probable role for thymic education in the development of tolerance to paren- 
chymal self. Evidence that T  tolerance to minor self-histocompatibility antigens 
is MHC restricted has also been recently reported by others (29, 30). 
Thus,  tubular antigen-reactive  T  cells are present  in  the  BN rat,  and  their 
expression after antigenic challenge is inhibited by a potent suppressor mecha- 
nism. Our studies, however, do not rule out an immunoprotective role for clonal 
deletion. Indeed, the two mechanisms may coexist. The majority of self-reactive 
clones,  for example,  may be inactivated  or deleted during  ontogeny,  and  for 
those  escaping  deletion,  suppressor  T  cells  function  as  a  backup  mechanism 
preventing  autoimmunity  (2).  In  such  a  model,  the  relative  importance  of 
suppressor cells would be greater after an event eliciting expansion of quiescent 
self-reactive clones.  The  suppressor cells we describe here are also probably a 
distinct population  from "veto" ceils which serve to inactivate self-reactive pre- 
cursor cells, as veto cells seem only to function during the generation of effector 
cell repertoires (31, 32). 
Our results are also consistent with observations made in several other models 
of autoimmunity. Immunodeficient mice immunized with modified-self antigens 
can display antigen-specific DTH responses, but such responses are not seen in 
normal  mice (33).  Thymic or splenic T  cells from normal  syngeneic mice can 
suppress this  reactivity (34).  These  suppressor cells are  Lyt-2  +,  I-J  +, and  their 
function  can  be  replaced  by  cell-derived  soluble  factors  (34-36).  Others,  in 
studying the autoimmune  lesions developing after reconstitution  of nude mice 
with cells from euthymic (nu/+) heterozygotes, have found that defined T  cell 
subpopulations can suppress the development of autoimmune disease (37). Sim- 
ilarly,  the lack of an immune response to self-protein  F may also be related,  in 
part, to activation of suppressor cells (38). Thus, suppressor mechanisms similar 
to  those  described  in  the  current  studies  may  exist  for  other  organ-specific 
autologous antigens. 
Summary 
BN rats develop interstitial  nephritis  after immunization  with rabbit, but not 
rat  renal  tubular  antigen.  Using  RT1 n rat  strains  that  differentially  express 
tubular antigen,  we investigated the unresponsiveness of BN rats to BN tubular 
antigen (BN-TBM) using delayed-type hypersensitivity (DTH) responses to BN- 
TBM  as  a  measure  of cell-mediated  immunity.  Our  results  indicate  that  rat 
strains expressing tubular antigen respond to immunization with BN-TBM with 
the  clonal  expansion  of  antigen-specific,  cyclophosphamide-sensitive,  OX8 +, 
MHC-restricted suppressor T  cells. Such suppression appears to be relevant  to 
the maintenance  of tolerance to parenchymal  self, since chronic cyclophospha- 
mide therapy abrogates suppression and results in significant interstitial nephritis. 
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